| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2007.04 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 2045.58 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 1943.5 | 98 |
| GSM780719 | Untreated after 4 days (C1_2) | 2064.73 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 2232.22 | 98 |
| GSM780721 | Untreated after 4 days (C3_2) | 2066.74 | 98 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 2019.95 | 98 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2085.74 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1828.11 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 2235.83 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 2163.08 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 2031.43 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1689.87 | 97 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1946.87 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1962.94 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1869.36 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1833.14 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2004.12 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 2122.71 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1862.27 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 2100.45 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 2055.22 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1835.17 | 98 |